Ads
related to: vertex pharmaceuticals diabetes- Contact Us
Find all the ways to reach us
for the information you need.
- News
Stay current on all things Vertex
and discover the latest news.
- Our Company
Learn about our mission and
the values that drive us.
- Our Unique Approach
See What Makes Us Unique
And How We Put Science First.
- Contact Us
Search results
Vertex Pharmaceuticals: Buy at the High?
Motley Fool· 2 years agoVertex Pharmaceuticals (NASDAQ: VRTX) has a lot going on these days. The biotech company is developing two candidates that could make it even stronger in...
Vertex Pharmaceuticals Stock: Bear vs. Bull
Motley Fool· 11 months agoVertex Pharmaceuticals (NASDAQ: VRTX) is heading toward a big moment: a regulatory decision on what may become its next game-changing product. Investors...
Where Will Vertex Pharmaceuticals Be in 10 Years?
Motley Fool· 6 months agoVertex Pharmaceuticals (NASDAQ: VRTX) has come a long way in the past ten years. In a little over a decade, the company has built a cystic fibrosis (CF)...
5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip
Motley Fool via Yahoo Finance· 3 weeks agoShares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 8% from a peak they reached this...
Is Vertex Pharmaceuticals Stock Too Expensive With a Price-to-Sales Ratio of 11x?
Motley Fool via Yahoo Finance· 3 months agoI've been a big fan of Vertex Pharmaceuticals (NASDAQ: VRTX), and the biotech stock has made me a...
Vertex (VRTX) Inks Licensing Deal With CRISPR for Diabetes Drug
Zacks via Yahoo Finance· 1 year agoVertex Therapeutics (VRTX) enters into a licensing agreement with CRISPR for the latter's...
2 Green Flags for Vertex Pharmaceuticals' Future
Motley Fool· 2 years agoBiotech Vertex Pharmaceuticals (NASDAQ: VRTX) is defying the stock market sell-off this year. While that's great news for shareholders, it's essential to...
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
The Motley Fool via AOL· 5 days agoVertex Pharmaceuticals (NASDAQ: VRTX) is a fast-growing pharmaceutical company that investors have been bullish on for years. The business generates...
This High-Flying Stock Just Got Some Bad News: Should You Sell?
Motley Fool via Yahoo Finance· 4 months agoBiotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) ended 2023 with an important regulatory...
Vertex Is 1 Step Closer to Bringing a New Blockbuster to Market. Time to Buy?
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) has been generating billion-dollar revenue for years, thanks...
Ad
related to: vertex pharmaceuticals diabetes
